ALLMedicine™ Venous Thromboembolism Center

Feb 22nd, 2021 - Dabigatran is a direct oral anticoagulant thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation and prophylaxis or treatment of venous thromboembolism. Since approval, there has been increasing concer...

Feb 22nd, 2021 - Pulmonary embolism (PE) recurrence is the primary factor affecting the prognoses of patients with venous thromboembolism (VTE). However, the major challenge physicians face in these patients is the possible risk of PE recurrence after treatment. G...

Feb 22nd, 2021 - Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Children.|2021|Caldwell A,Moss S,Jenkins A,Herbst B,|

Feb 21st, 2021 - Leisure-time cross-country skiing and the risk of venous thromboembolism: A prospective cohort study.|2021|Kunutsor SK,Lakka TA,Kurl S,Mäkikallio TH,Jae SY,|

Feb 21st, 2021 - Few studies have so far focused on the preoperative presence of venous thromboembolism (VTE) in lung cancer patients undergoing surgery. In this study, we investigated the prevalence and risk factors for preoperative deep venous thrombosis (DVT) i...

Nov 30th, 2020 - 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Re...

Nov 11th, 2020 - Observational studies indicate that children hospitalized with COVID-19-related illness, like adults, are at increased risk for venous thromboembolism (VTE). A multicenter phase 2 clinical trial of anticoagulant thromboprophylaxis in children hosp...

May 27th, 2020 - Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.|2020|Spyropoulos AC,Levy JH,Ageno W,Connors JM,Hunt BJ,|adminis...

May 20th, 2020 - Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing.|2020|McCormack T,Harrisingh MC,Horner D,Bewley S, ,|therapeutic use,standards,therapeutic use,drug therapy,epidemiology,therape...

May 3rd, 2020 - Venous thromboembolism is a major cause of maternal morbidity and mortality. The risk of venous thromboembolism is particularly elevated during the postpartum period and especially after cesarean delivery. There is considerable variation in the ap...

Feb 22nd, 2021 - Dabigatran is a direct oral anticoagulant thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation and prophylaxis or treatment of venous thromboembolism. Since approval, there has been increasing concer...

Feb 22nd, 2021 - Pulmonary embolism (PE) recurrence is the primary factor affecting the prognoses of patients with venous thromboembolism (VTE). However, the major challenge physicians face in these patients is the possible risk of PE recurrence after treatment. G...

Feb 22nd, 2021 - Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Children.|2021|Caldwell A,Moss S,Jenkins A,Herbst B,|

Feb 21st, 2021 - Leisure-time cross-country skiing and the risk of venous thromboembolism: A prospective cohort study.|2021|Kunutsor SK,Lakka TA,Kurl S,Mäkikallio TH,Jae SY,|

Feb 21st, 2021 - Few studies have so far focused on the preoperative presence of venous thromboembolism (VTE) in lung cancer patients undergoing surgery. In this study, we investigated the prevalence and risk factors for preoperative deep venous thrombosis (DVT) i...

Dec 22nd, 2020 - The American College of Cardiology (ACC) has released a new Expert Consensus Decision Pathway (ECDP) on the use of anticoagulant and antiplatelet therapy in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) undergoing percutan...

Dec 1st, 2020 - When a patient with cancer develops venous thromboembolism despite anticoagulation, how to help them comes down to clinical judgment, according to hematologist Neil Zakai, MD, associate professor at the University of Vermont, Burlington. "Unfortun...

Nov 17th, 2020 - The guidelines on the use of inferior vena cava (IVC) filters in the treatment of patients with venous thromboembolism (VTE; ie, deep vein thrombosis [DVT] or pulmonary embolism [PE]) were published in October 2020 by the Society of Interventional...

Nov 17th, 2020 - The guidelines on the use of inferior vena cava (IVC) filters in the treatment of patients with venous thromboembolism (VTE; ie, deep vein thrombosis [DVT] or pulmonary embolism [PE]) were published in October 2020 by the Society of Interventional...

Nov 16th, 2020 - Cancer patients who receive an immune checkpoint inhibitor have more than a doubled rate of venous thromboembolism during the subsequent 2 years, compared with their rate during the 2 years before treatment, according to a retrospective analysis o...